321 related articles for article (PubMed ID: 28233679)
1. Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain.
Teleb M; Zhang FX; Huang J; Gadotti VM; Farghaly AM; AboulWafa OM; Zamponi GW; Fahmy H
Bioorg Med Chem; 2017 Mar; 25(6):1926-1938. PubMed ID: 28233679
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of new N3-substituted dihydropyrimidine derivatives as L-/T- type calcium channel blockers.
Teleb M; Zhang FX; Farghaly AM; Aboul Wafa OM; Fronczek FR; Zamponi GW; Fahmy H
Eur J Med Chem; 2017 Jul; 134():52-61. PubMed ID: 28399450
[TBL] [Abstract][Full Text] [Related]
3. Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-/T-type calcium channel blocking activity.
Schaller D; Gündüz MG; Zhang FX; Zamponi GW; Wolber G
Eur J Med Chem; 2018 Jul; 155():1-12. PubMed ID: 29843108
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of some new C2 substituted dihydropyrimidines and their electrophysiological evaluation as L-/T-type calcium channel blockers.
Teleb M; Rizk OH; Zhang FX; Fronczek FR; Zamponi GW; Fahmy H
Bioorg Chem; 2019 Jul; 88():102915. PubMed ID: 31005784
[TBL] [Abstract][Full Text] [Related]
5. Structural optimization, synthesis and in vitro synergistic anticancer activities of combinations of new N3-substituted dihydropyrimidine calcium channel blockers with cisplatin and etoposide.
El-Wakil MH; Teleb M; Abu-Serie MM; Huang S; Zamponi GW; Fahmy H
Bioorg Chem; 2021 Oct; 115():105262. PubMed ID: 34411980
[TBL] [Abstract][Full Text] [Related]
6. 1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain.
Bladen C; Gadotti VM; Gündüz MG; Berger ND; Şimşek R; Şafak C; Zamponi GW
Pflugers Arch; 2015 Jun; 467(6):1237-47. PubMed ID: 24990197
[TBL] [Abstract][Full Text] [Related]
7. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
[TBL] [Abstract][Full Text] [Related]
8. Focusing on C-4 position of Hantzsch 1,4-dihydropyridines: Molecular modifications, enantioseparation, and binding mechanism to L- and T-type calcium channels.
Akman D; Denzinger K; Huang S; Lee JT; Nafie JW; Wolber G; Zamponi GW; Armstrong DW; Gündüz MG
Eur J Med Chem; 2022 Dec; 244():114787. PubMed ID: 36209630
[TBL] [Abstract][Full Text] [Related]
9. Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels.
Gadotti VM; Bladen C; Zhang FX; Chen L; Gündüz MG; Şimşek R; Şafak C; Zamponi GW
Pflugers Arch; 2015 Dec; 467(12):2485-93. PubMed ID: 26286466
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and pharmacological evaluation of some substituted dihydropyrimidines with L-/T-type calcium channel blocking activities.
Teleb M; Rizk OH; Zhang FX; Fronczek FR; Zamponi GW; Fahmy H
Bioorg Chem; 2019 Mar; 83():354-366. PubMed ID: 30408648
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity.
Bladen C; Gündüz MG; Şimşek R; Şafak C; Zamponi GW
Pflugers Arch; 2014 Jul; 466(7):1355-63. PubMed ID: 24149495
[TBL] [Abstract][Full Text] [Related]
12. Characterization of novel cannabinoid based T-type calcium channel blockers with analgesic effects.
Bladen C; McDaniel SW; Gadotti VM; Petrov RR; Berger ND; Diaz P; Zamponi GW
ACS Chem Neurosci; 2015 Feb; 6(2):277-87. PubMed ID: 25314588
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of a disubstituted piperazine derivative with T-type channel blocking action and analgesic properties.
Pudukulatham Z; Zhang FX; Gadotti VM; M'Dahoma S; Swami P; Tamboli Y; Zamponi GW
Mol Pain; 2016; 12():. PubMed ID: 27053601
[TBL] [Abstract][Full Text] [Related]
14. Blockade of T-type calcium channels by 6-prenylnaringenin, a hop component, alleviates neuropathic and visceral pain in mice.
Sekiguchi F; Fujita T; Deguchi T; Yamaoka S; Tomochika K; Tsubota M; Ono S; Horaguchi Y; Ichii M; Ichikawa M; Ueno Y; Koike N; Tanino T; Nguyen HD; Okada T; Nishikawa H; Yoshida S; Ohkubo T; Toyooka N; Murata K; Matsuda H; Kawabata A
Neuropharmacology; 2018 Aug; 138():232-244. PubMed ID: 29913186
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of Pseudellone Analogs and Characterization as Novel T-type Calcium Channel Blockers.
Wang D; Neupane P; Ragnarsson L; Capon RJ; Lewis RJ
Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30487473
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.
Woo HM; Lee YS; Roh EJ; Seo SH; Song CM; Chung HJ; Pae AN; Shin KJ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5910-5. PubMed ID: 21843937
[TBL] [Abstract][Full Text] [Related]
17. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
[TBL] [Abstract][Full Text] [Related]
18. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
[TBL] [Abstract][Full Text] [Related]
19. TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent.
Choe W; Messinger RB; Leach E; Eckle VS; Obradovic A; Salajegheh R; Jevtovic-Todorovic V; Todorovic SM
Mol Pharmacol; 2011 Nov; 80(5):900-10. PubMed ID: 21821734
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of pyrrolidine-based T-type calcium channel inhibitors for the treatment of neuropathic pain.
Yang HK; Son WS; Lim KS; Kim GH; Lim EJ; Gadhe CG; Lee JY; Jeong KS; Lim SM; Pae AN
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1460-1471. PubMed ID: 30231778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
